Moreadith Randall
Chief Scientific Officer
1 company
Insider Signal Score
73
StrongTrades Analyzed
37
12M Win Rate
-
Avg 3M Return
+31.7%
Avg 12M Return
-
Moreadith Randall is a Chief Scientific Officer at Serina Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Holdings by Company
SERMar 23, 2026
Current Shares0
Value-
Net Activity-253,500
Bought: 0Sold: 253.5K
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 6,500 | $2.86 | $18,567.90 | -100% | -33.3% | - | |
| Mar 19, 2026 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 39,000 | $2.50 | $97,500.00 | -100% | -20.2% | - | |
| Feb 2, 2026 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 6,500 | $3.03 | $19,680.05 | -100% | -33.2% | - | |
| Jan 28, 2026 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 6,500 | $3.57 | $23,185.50 | -100% | -32.0% | - | |
| Jan 22, 2026 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,500 | $2.95 | $7,375.00 | -100% | - | - | |
| Jan 21, 2026 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 4,000 | $3.04 | $12,140.00 | -100% | - | - | |
| Jan 14, 2026 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 6,500 | $2.50 | $16,253.36 | -100% | -25.8% | - | |
| Jan 8, 2026 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 13,000 | $2.69 | $34,953.10 | -100% | -22.9% | - | |
| Dec 23, 2025 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 4,100 | $2.60 | $10,660.00 | -100% | +25.0% | - | |
| Dec 22, 2025 | SER Serina Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 5,673 | $2.67 | $15,167.90 | -100% | +18.9% | - |
Page 1Next →